Modal DNA-Values in Prostate Cancer Patients with Deferred Therapy or Endocrine Therapy

Authors

  • J. Adolfsson DEPARTMENT OF UROLOGY AND RADIOBIOLOGY, KAROLINSKA HOSPITAL, STOCKHOLM, SWEDEN
  • B. Tribukait DEPARTMENT OF UROLOGY AND RADIOBIOLOGY, KAROLINSKA HOSPITAL, STOCKHOLM, SWEDEN

DOI:

https://doi.org/10.3109/02841869109092352

Keywords:

Prostate cancer, modal DNA-value, deferred therapy, endocrine therapy, survival

Abstract

Modal DNA-values were assessed with Pow cytometry ir. 269 patients with newly detected untreated prostate cancer. One hundred and seventy-two patients with low-grade, low-stage, non-metastasized cancers were followed without treatment and in this group initial tumor ploidy had no prognostic value. Ninety-seven patients with clinically more advanced prostat: cancers were subjected to endocrine therapy and in this group ploidy was prognostic regarding cancer-related sunival.

Downloads

Download data is not yet available.

Downloads

Published

1991-01-01

How to Cite

Adolfsson, J., & Tribukait, B. (1991). Modal DNA-Values in Prostate Cancer Patients with Deferred Therapy or Endocrine Therapy. Acta Oncologica, 30(2), 209–210. https://doi.org/10.3109/02841869109092352

Issue

Vol. 30 No. 2 (1991): Acta Oncologica

Section

Articles